Zytiga — Medica
Prostate cancer – regional risk group
Initial criteria
- age ≥ 18 years
- used in combination with prednisone
- regional lymph node metastases and no distant metastases
- ONE of the following: concurrently used with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy
Approval duration
1 year